Macrogenics Inc (NASDAQ:MGNX) shares, rose in value on Wednesday, July 09, with the stock price up by 8.16% to the previous day’s close as strong demand from buyers drove the stock to $1.59.
Actively observing the price movement in the last trading, the stock closed the session at $1.47, falling within a range of $1.465 and $1.6. The value of beta (5-year monthly) was 1.632. Referring to stock’s 52-week performance, its high was $5.77, and the low was $0.99. On the whole, MGNX has fluctuated by -10.67% over the past month.
With the market capitalization of Macrogenics Inc currently standing at about $100.31 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-13.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 91.68M, with a low estimate of 7.5M and a high estimate of 75.9M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 28.06M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MGNX’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of MGNX currently trading nearly 12.49% and 6.44% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 58.28, while the 7-day volatility ratio is showing 10.05% which for the 30-day chart, stands at 9.87%. Furthermore, Macrogenics Inc (MGNX)’s beta value is 1.62.
A comparison of Macrogenics Inc (MGNX) with its peers suggests the former has fared considerably weaker in the market. MGNX showed an intraday change of 8.16% in last session, and over the past year, it shrunk by -51.08%%.
Data on historical trading for Macrogenics Inc (NASDAQ:MGNX) indicates that the trading volumes over the past 10 days have averaged 1.73 and over the past 3 months, they’ve averaged 1.24 million. According to company’s latest data on outstanding shares, there are 63.09 million shares outstanding.
Nearly 8.16% of Macrogenics Inc’s shares belong to company insiders and institutional investors own 80.23% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 5.53 million shares as on 2025-06-13, resulting in a short ratio of 3.17. According to the data, the short interest in Macrogenics Inc (MGNX) stood at 1080.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 6.09 million. The stock has fallen by -62.14% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MGNX stock heading into the next quarter.
